Pheochromocytomas and Paragangliomas.
Extra-adrenal pheochromocytoma
Hypertension
Neuroendocrine tumors
Paragangliomas
Pheochromocytomas
Journal
Endocrinology and metabolism clinics of North America
ISSN: 1558-4410
Titre abrégé: Endocrinol Metab Clin North Am
Pays: United States
ID NLM: 8800104
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
entrez:
28
10
2019
pubmed:
28
10
2019
medline:
21
4
2020
Statut:
ppublish
Résumé
Pheochromocytomas are rare neuroendocrine tumors. Extra-adrenal lesions arising from the autonomic neural ganglia are termed paraganglioma. Clinical symptoms are common between the adrenal and extra-adrenal forms and are determined by excess secretion of catecholamines. Hypertension is a critical and often dramatic feature of pheochromocytoma/paraganglioma, and its most prevalent reported symptom. However, given the rare occurrence of this cancer, in patients undergoing screening for hypertension, the prevalence ranges from 0.1% to 0.6%. Still, patients frequently come to the attention of endocrinologist when pheochromocytoma/paraganglioma is suspected as a secondary cause of hypertension. This article summarizes current clinical approaches in patients with pheochromocytoma/paraganglioma.
Identifiants
pubmed: 31655773
pii: S0889-8529(19)30060-X
doi: 10.1016/j.ecl.2019.08.006
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
727-750Informations de copyright
Published by Elsevier Inc.